Delabeling penicillin allergy in a pediatric primary care clinic

Abstract

Reported adverse drug reactions to penicillins are common, affecting between 10-20% of the North American population; however, more than 90% of patients with a penicillin allergy label can safely tolerate penicillins 1, 2. Numerous adverse outcomes are associated with labeled penicillin allergy 1, 2. In light of this, appropriate diagnosis and verification of a penicillin allergy label is crucial to achieving optimal health outcomes and has been recommended by the Centers for Disease Control and Prevention, the American College of Allergy, Asthma, and Immunology, and the American Academy of Allergy, Asthma, and Immunology 3.